Matches in Wikidata for { <http://www.wikidata.org/entity/Q37269566> ?p ?o ?g. }
- Q37269566 description "article científic" @default.
- Q37269566 description "article scientifique" @default.
- Q37269566 description "articolo scientifico" @default.
- Q37269566 description "artigo científico" @default.
- Q37269566 description "artículu científicu espublizáu en 2015" @default.
- Q37269566 description "bilimsel makale" @default.
- Q37269566 description "scientific article published on 28 April 2015" @default.
- Q37269566 description "vedecký článok" @default.
- Q37269566 description "vetenskaplig artikel" @default.
- Q37269566 description "videnskabelig artikel" @default.
- Q37269566 description "vědecký článek" @default.
- Q37269566 description "wetenschappelijk artikel" @default.
- Q37269566 description "wissenschaftlicher Artikel" @default.
- Q37269566 description "наукова стаття, опублікована у квітні 2015" @default.
- Q37269566 description "научни чланак" @default.
- Q37269566 description "مقالة علمية نشرت في 28 أبريل 2015" @default.
- Q37269566 name "Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial" @default.
- Q37269566 name "Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial" @default.
- Q37269566 name "Longer-term follow-up and outcome by tumour cell proliferation rate" @default.
- Q37269566 type Item @default.
- Q37269566 label "Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial" @default.
- Q37269566 label "Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial" @default.
- Q37269566 label "Longer-term follow-up and outcome by tumour cell proliferation rate" @default.
- Q37269566 prefLabel "Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial" @default.
- Q37269566 prefLabel "Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial" @default.
- Q37269566 prefLabel "Longer-term follow-up and outcome by tumour cell proliferation rate" @default.
- Q37269566 P1104 Q37269566-4615CE54-9D4E-4753-8B6E-BAD35B0BA63B @default.
- Q37269566 P1433 Q37269566-30DA3F08-028E-402F-B3D0-1C04A10A0CF6 @default.
- Q37269566 P1476 Q37269566-3F8E1FEF-D54D-4CA7-9FE6-1EB33D77F298 @default.
- Q37269566 P2093 Q37269566-05F99561-AF1A-42B1-954B-996F118E91E2 @default.
- Q37269566 P2093 Q37269566-42FC94F0-6D7F-4E09-838E-527F9F30A925 @default.
- Q37269566 P2093 Q37269566-4CB53DB5-9B2A-4F0A-B9F7-D8010E2422B9 @default.
- Q37269566 P2093 Q37269566-5B6DE8D8-20A0-4FD8-9F15-713626F71269 @default.
- Q37269566 P2093 Q37269566-5C710341-E512-48B4-8336-40DC38E14E6C @default.
- Q37269566 P2093 Q37269566-68758213-D5D4-44AB-B023-AEA0FA2EF8C1 @default.
- Q37269566 P2093 Q37269566-7AF9D28E-494D-4459-BD36-8B39733BD9AE @default.
- Q37269566 P2093 Q37269566-BEB7F1C2-B2D0-4BBA-95D9-BC7ACD6AA146 @default.
- Q37269566 P2093 Q37269566-D0AE1275-3385-4247-99E1-AC2B9C0E88BC @default.
- Q37269566 P2093 Q37269566-D59149D9-03EA-43C2-83AE-10F5CE2B1B27 @default.
- Q37269566 P2093 Q37269566-D975B557-7A95-4100-8D7D-A4AD62BED845 @default.
- Q37269566 P2860 Q37269566-005E30E9-EAC4-40A2-9C18-FC7620A66FA7 @default.
- Q37269566 P2860 Q37269566-20D84685-BF06-485D-ADFB-10F02019E7A8 @default.
- Q37269566 P2860 Q37269566-3C23B70B-404C-458E-ABF3-096502E22041 @default.
- Q37269566 P2860 Q37269566-4754AF13-9EA0-4CFC-A5E9-FC0166119A89 @default.
- Q37269566 P2860 Q37269566-4B09241D-1371-4219-9B49-FE5FDFAC91C3 @default.
- Q37269566 P2860 Q37269566-4C4C100B-9F06-4435-B881-A261801ABFEC @default.
- Q37269566 P2860 Q37269566-5E82CF52-1F81-4DA9-8567-99FF804B1922 @default.
- Q37269566 P2860 Q37269566-691F5274-AA3F-4BB4-AFA7-93B6813EE1C2 @default.
- Q37269566 P2860 Q37269566-876BCE0B-425A-4E73-8F0A-E1750A555152 @default.
- Q37269566 P2860 Q37269566-8EA36D22-410E-4E09-A10B-D122503CA592 @default.
- Q37269566 P2860 Q37269566-96E2F5AC-7248-48D9-8BF3-4CB3E7210962 @default.
- Q37269566 P2860 Q37269566-A4D4E55B-055A-4891-BA8D-7B7A326FB223 @default.
- Q37269566 P2860 Q37269566-A64B392A-67DC-4A66-8077-F59E73CD1432 @default.
- Q37269566 P2860 Q37269566-AF5A42EF-AE95-4968-A895-0347EC77560C @default.
- Q37269566 P2860 Q37269566-B8161B95-1401-4014-9BD8-B54B2FC66B3F @default.
- Q37269566 P2860 Q37269566-C54B091B-5E90-4510-A1FD-C50A68EFBB1D @default.
- Q37269566 P2860 Q37269566-C72F36CE-8AE0-4306-8E75-18106A44539F @default.
- Q37269566 P2860 Q37269566-C9B75A3B-649C-4774-97FF-476316232CD9 @default.
- Q37269566 P2860 Q37269566-D205B6EA-6A12-4148-9266-7FA1FD982981 @default.
- Q37269566 P2860 Q37269566-DE8494D5-EE39-437F-A416-F91FA30D2DEE @default.
- Q37269566 P2860 Q37269566-DE86C226-1656-4C83-A850-1AA1A07FFFFB @default.
- Q37269566 P2860 Q37269566-EA92349B-E3FC-4978-856E-79799FE8D69D @default.
- Q37269566 P2860 Q37269566-FAADA924-4780-456C-A08E-F2921426B93D @default.
- Q37269566 P304 Q37269566-37686C12-6887-429F-90B5-1D4B029C9500 @default.
- Q37269566 P31 Q37269566-BF353194-9952-4CE5-8C49-A37CA9AC8B47 @default.
- Q37269566 P356 Q37269566-339E2FFE-A3F1-49DF-B3D7-54D9AEA84972 @default.
- Q37269566 P407 Q37269566-3B8DE954-96CA-4018-B445-58B896EDCCFA @default.
- Q37269566 P433 Q37269566-A8AAD4A0-E1B8-46EE-AE42-F7AD0E1063BF @default.
- Q37269566 P478 Q37269566-6A816C0D-1649-41BF-BC3F-93D08B28C474 @default.
- Q37269566 P50 Q37269566-39978121-0292-4EF4-918D-664A450953F1 @default.
- Q37269566 P50 Q37269566-A77AB394-3694-4E33-9194-287D104011AA @default.
- Q37269566 P577 Q37269566-07A6908A-B032-496C-B0A6-1140A94BECF7 @default.
- Q37269566 P5875 Q37269566-D35EB7D1-9A29-4D34-9CDD-3433D2C0C0D1 @default.
- Q37269566 P698 Q37269566-239097F2-2B03-44A8-A9E4-8EA6783410AD @default.
- Q37269566 P921 Q37269566-F95E3FEF-9C4F-47D4-AA1B-25B10C211673 @default.
- Q37269566 P932 Q37269566-D2DF4DB9-E64D-4D6B-A490-6B5493D77B2A @default.
- Q37269566 P356 BJH.13456 @default.
- Q37269566 P698 25921098 @default.
- Q37269566 P1104 "+8" @default.
- Q37269566 P1433 Q4970200 @default.
- Q37269566 P1476 "Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial" @default.
- Q37269566 P2093 "Achiel Van Hoof" @default.
- Q37269566 P2093 "Andre Goy" @default.
- Q37269566 P2093 "Jacob M Rowe" @default.
- Q37269566 P2093 "Johannes Drach" @default.
- Q37269566 P2093 "Lei Zhang" @default.
- Q37269566 P2093 "Michael J Robertson" @default.
- Q37269566 P2093 "Radhakrishnan Ramchandren" @default.
- Q37269566 P2093 "Sevgi Kalayoglu Besisik" @default.
- Q37269566 P2093 "Sherri Cicero" @default.
- Q37269566 P2093 "Thomas Witzig" @default.
- Q37269566 P2093 "Tommy Fu" @default.
- Q37269566 P2860 Q25938997 @default.
- Q37269566 P2860 Q28239256 @default.
- Q37269566 P2860 Q28254924 @default.
- Q37269566 P2860 Q30358639 @default.
- Q37269566 P2860 Q30649483 @default.
- Q37269566 P2860 Q33372761 @default.
- Q37269566 P2860 Q33380246 @default.
- Q37269566 P2860 Q33383459 @default.